Here's Why You Should Add Maximus Stock to Your Portfolio Now

Maximus, Inc. (MMS) is highlighted as a compelling investment opportunity due to its solid financial performance, strategic acquisitions, and strong government partnerships, earning a Zacks Rank #2 (Buy) and VGM Score of B. The consensus estimate for fiscal 2025 earnings is $6.23, a 2.5% increase over the past 60 days, with upward earnings revisions. The company's consistent dividend payments, most recently $72.9 million in fiscal 2024, and a current ratio of 1.84, exceeding the industry average, further support its financial stability and growth prospects.

Analysis

Maximus, Inc. (MMS) is presented as a strong investment opportunity, supported by a Zacks Rank #2 (Buy) and a VGM Score of B, indicative of robust fundamentals and growth potential. The fiscal 2025 earnings consensus estimate for MMS has increased by 2.5% to $6.23 over the past 60 days, driven by one upward revision and no downward revisions, signaling positive analyst sentiment. With over four decades of experience, Maximus has established itself as a leading operator of government health and human services programs, benefiting from long-term contracts that ensure predictable, recurring revenue streams. The company's strategic acquisitions, including Stirling Institute of Australia and BZ Bodies, have been instrumental in expanding its business processes, technical capabilities, and client relationships, complementing its organic growth. Maximus's financial health is further underscored by a consistent history of dividend payments, amounting to $72.9 million in fiscal 2024, and a strong liquidity position, reflected in a current ratio of 1.84 as of the end of Q2 fiscal 2025, which surpasses the industry average of 1.52.

Key Decisions for Investors

• Investors may find Maximus (MMS) an attractive investment, considering its favorable Zacks rating, positive earnings estimate revisions, and established position in providing essential government services.
• The company's strategy of growth through acquisitions and its history of stable dividend payments ($72.9 million in fiscal 2024) suggest a balanced approach to expansion and shareholder returns, warranting consideration for portfolios seeking both growth and income.
• Monitoring the renewal and expansion of government contracts, alongside the successful integration of new acquisitions, will be key indicators of Maximus's continued performance and ability to meet its growth expectations.